Follicular Lymphoma | Tumor

The Top 5 News and Updates in Follicular Lymphoma That Patients May Have Missed in 2020

December 30th 2020, 10:00pm

Article

A roundup of some of the most read news and updates in follicular lymphoma in 2020 from CURE®.

One-Half Teaspoon

December 26th 2020, 7:00pm

Article

Aileen Holthaus writes about her first day of chemotherapy for follicular lymphoma, and the challenges it presented.

Novel Drugs Look Promising in the Treatment of Follicular Lymphoma

November 4th 2020, 4:00pm

Article

One recently approved drug and two experimental treatments offer the promise of a wider range of options for patients with follicular lymphoma, according to Dr. Germame Ajebo.

Trading Places: A Father and Daughter's Journey with Lymphoma

October 30th 2020, 6:00pm

Article

Bob Meyers and his daughter Leslie Watson have always been close. In fact, they live right down the street from one another in their Georgia neighborhood. So, when Watson received the diagnosis of clear cell carcinoma in the summer of 1996, and then follicular lymphoma later that fall, Meyers was there by her side as her devoted caregiver.

Tazverik a Safe and Effective Option for Heavily Pretreated Patients with Follicular Lymphoma

October 27th 2020, 9:00pm

Article

In addition to showing clinically meaningful, durable responses, Tazverik (tazemetostat) was generally well-tolerated in heavily pretreated patients with relapsed or refractory follicular lymphoma, according to the results of an open-label, single-arm, multicenter phase 2 study.

Aliqopa in Combination with Rituxan Meets Primary End Point for Indolent Non-Hodgkin’s Lymphoma

October 16th 2020, 6:00pm

Article

A study evaluating the efficacy of Aliqopa (copanlisib) in combination with Rituxan (rituximab) in patients with indolent non-Hodgkin’s lymphoma who have relapsed after at least one prior line of therapy also involving Rituxan has met its primary endpoint, according to Aliqopa’s manufacturer, Bayer.

Follicular Lymphoma Treatment Could Rely on Immunotherapy in Therapy Sequencing

October 15th 2020, 9:00pm

Video

Follicular lymphoma treatment options are changing, and according to one expert, immunotherapy could become a major part of therapy sequencing.

Expert Discusses the Need for Safe and Effective Treatments for Aggressive Follicular Lymphoma

October 14th 2020, 9:00pm

Video

Dr. Kami J. Maddocks discusses the importance of effective treatments for patients with aggressive follicular lymphoma and the treatment challenges they face.

Consolidative High-Dose Therapy, Autologous Stem Cell Transplant After R-CHOP for Follicular Lymphoma Does Not Improve Survival

October 7th 2020, 3:00pm

Article

“Collectively, our mature data provide the most definitive evidence supporting current guidelines, that HDT/ASCT should not be offered to unselected patient(s) (with follicular lymphoma) in the frontline setting,” the authors wrote.

Phase 2 Interim Analysis Shows Improved Response in Patients with Follicular Lymphoma

August 12th 2020, 4:00am

Article

“These results further support our efforts to reimagine medicine in this incurable malignancy and reach this underserved patient population, who are historically burdened with several years of various treatments,” said Dr. John Tsai.